Free-living Home Use of an Artificial Beta Cell in Type 1 Diabetes

JDRF (22-2011-668) and Seventh Framework Programme of the European Union (ICT FP7- 247138). Additional support for the Artificial Pancreas work by National Institute for Health Research Cambridge Biomedical Research Centre and Wellcome Strategic Award (100574/Z/12/Z). Abbott Diabetes Care supplied discounted continuous glucose monitoring devices, sensors, and details of communication protocol to facilitate real-time connectivity. Diasend provided discounted platform for data upload.